Exosomes Market Outlook:
Exosomes Market size was valued at USD 215.79 million in 2025 and is set to exceed USD 1.63 billion by 2035, expanding at over 22.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of exosomes is estimated at USD 259.29 million.
The growth of the market is due to an increase in percentage of the people suffering from neurodegenerative diseases which is the main cause of death and disability, as well as a significant financial strain on healthcare systems. In strongly growing nations, the number of dementia cases is predicted to rise from 13.5 million in 2000 to 21.2 million in 2025 and 36.7 million in 2050, according to a United Nations assessment.
In addition to these, the market is growing since major firms have been making developments on exosome therapies. For example, in 2021, the biotechnology research company Cell Guidance Systems, located in the United States, announced that it would be creating exosome therapies to treat COVID-19. Furthermore, there will probably be a significant increase in government and non-government initiatives for exosome research during the study period.
